Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing ...
Big Tech's capital spending is up significantly, with Meta, Microsoft and Google leading the charge in AI infra. Hidden win...
UBS analyst Joseph Spak maintains Amphenol (NYSE:APH) with a Buy and raises the price target from $145 to $152.
Goldman Sachs analyst Mark Delaney maintains Amphenol (NYSE:APH) with a Buy and raises the price target from $139 to $154.
JP Morgan analyst Samik Chatterjee maintains Amphenol (NYSE:APH) with a Overweight and raises the price target from $145 to ...
